Skip to content

Serotonin: all studies

Page 114 of 400: studies 1,131 to 1,140 of 3,999, newest first. Back to the serotonin overview

Research

Role of serotonin in the discriminative stimulus properties of mescaline

Pharmacology, Biochemistry, and Behavior May 1, 1975 Ronald G. Browne, Beng T. Ho 51 citations

Rats were trained to discriminate intraperitoneally administered mescaline from saline in a two-lever operant chamber for food reinforcement. Reward was contingent upon responses made greater than 15 sec apart (DRL-15) on the appropriate lever paired with either drug or saline administration. Following the establishment of discriminative response control by mescaline, the animals were tested...

Opposite effects of intraventricular serotonin and bufotenin on rat startle responses.

Pharmacology, Biochemistry, and Behavior 1975 Mark A. Geyer, J D Warbritton, D B Menkes et al. 34 citations

Rat startle responses to air puffs were monitored in a stabilimeter during the intraventricular infusion of various doses of 5-hydroxytrptamine (5-HT) or the putative hallucinogenic congener of 5-HT, 5-hydroxy-N, N-dimethyltrytamine (5-HDMT) or saline. Qualitativity opposite effects were observed, with 5-HT producing a dose-dependent decrease in responsivity and 5-HDMT increasing the magnitude...

Serotonin-Sensitive Adenylate Cyclase in Neural Tissue and Its Similarity to the Serotonin Receptor: A Possible Site of Action of Lysergic Acid Diethylamide

Proceedings of the National Academy of Sciences March 1, 1974 James A. Nathanson, Paul Greengard 95 citations

An adenylate cyclase (EC 4.6.1.1) that is activated specifically by low concentrations of serotonin has been identified in homogenates of the thoracic ganglia of an insect nervous system. The activation of this enzyme by serotonin was selectively inhibited by extremely low concentrations of D-lysergic acid diethylamide (LSD), 2-bromo-LSD, and cyproheptadine, agents which are known to block...

Lysergic acid diethylamide: Role in conversion of plasma tryptophan to brain serotonin (5-hydroxytryptamine)

Science 1969 Robert C. Lin, S. H. Ngai, E. Costa 69 citations

Injections of D-lysergic acid diethylamide decrease the turnover rate of 5-hydroxytryptamine of rat brain, as measured from the conversion of (14)C-tryptophan into (14)C-5-hydroxytryptamine. The 2-bromolysergic acid diethylamide given in doses fivefold greater than those of lysergic acid diethylamide fails to change the rate of (14)C-tryptophan conversion into (14)C-5-hydroxytryptamine. The...

Serotonin Release from Brain Slices by Electrical Stimulation: Regional Differences and Effect of LSD

Science September 22, 1967 Thomas N. Chase, George R. Breese, Irwin J. Kopin 1 citation

Slices of rat brain which had accumulated tritiated serotonin either in vivo or in vitro were superfused and electrically stimulated. There occurred a marked release of the exogenous amine and, to a lesser extent, its deaminated metabolites, which varied with the region of brain tested and was inhibited by lysergic acid diethylamide.

Effects of LSD-25 on brain serotonin.

Journal of Pharmacology and Experimental Therapeutics November 1, 1961 D. X. Freedman

LSD-25 in doses of 130 to 1300 µg/kg induced a small and significant rise in levels of rat brain serotonin within 10 to 120 minutes following administration. A single dose was as effective as several daily doses. In reserpine treated animals, LSD-25 induced a 2-fold elevation in brain serotonin, and effects were found 96 hours following a single dose of LSD-25. A dose-effect interaction of...

Effects of Hallucinogenic and Tranquilizing Drugs on Serotonin Evoked Uterine Contractions.

Experimental Biology and Medicine 1956 E. Costa 64 citations

SummaryTranquilizing drugs: Frenquel (0.8 mg/1), chlorpromazine (0.1 mg/1) and reserpine (0.4 mg/1), antagonize serotonin-induced uterine contractions, though they do not affect sensitivity of the uterus of the spayed rat either to ACh or oxytocin. The period of antagonism is longer lasting with reserpine than with chlorpromazine and is shortest with Frenquel. Mescaline (0.1 mg/1) causes a...

A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.

Journal of Clinical Psychopharmacology Nicole Ledwos, Joshua D. Rosenblat, Daniel M. Blumberger et al. 16 citations

There has been resurgence of interest in the therapeutic use of serotonergic ("classic") psychedelics in major depressive disorder (MDD) and end-of-life distress. This commentary offers a critical appraisal of current evidence for antidepressant effects of classic psychedelics from contemporary clinical trials and highlights pitfalls that should be addressed before clinical translation. A...

DOI: 10.1097/jcp.0000000000001608 (opens in new tab) Full text (opens in new tab) Psychedelic therapy Mental health treatment Clinical research Depression treatment +1

Quantum Chemical Topology and Energetic Analysis of Psychedelic and Non-Psychedelic Ligands in Coordination-Sphere Models of the Human 5-HT2A Receptor

Anaid Flores, Imelda Lizeth Lazcano-Carrasco, Mayra Lozano-Espinosa et al. preprint

Abstract Psychedelic compounds have shown promising efficacy in the treatment of psychiatric disorders, yet the electronic features of their recognition by the serotonin 2A receptor (5-HT 2A ) remain poorly characterized. Here, we present a quantum-chemical analysis of local ligand–receptor models derived from the experimental 5-HT 2A structures of six ligands: serotonin, psilocin, lysergic...